Shareholders' (Deficit) Equity - Underwriting Agreement (Details) |
Feb. 28, 2024
$ / shares
shares
|
|---|---|
| Pre-funded warrants | |
| Authorized share capital | |
| Share price (in dollar per share) | $ / shares | $ 1.499 |
| Warrants issued to purchase shares | shares | 3,333,333 |
| Warrants exercise price | $ / shares | $ 0.001 |
| Pre-funded warrants | Maximum | |
| Authorized share capital | |
| Number of shares issued during the period | shares | 3,000,000 |
| Underwriters | |
| Authorized share capital | |
| Number of shares issued during the period | shares | 16,666,667 |
| Share price (in dollar per share) | $ / shares | $ 1.5 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|